Where on Leg to Inject Wegovy: A Comprehensive Guide

Last reviewed: July 7, 2026

Last updated: July 7, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide injections work best when placed in the right subcutaneous tissue layer, typically on the thigh or outer hip. PlexusDx provides compounded semaglutide from licensed 503A pharmacies, and knowing where and how to inject ensures consistent medication absorption and reduces injection-site reactions.

Approved Leg Injection Sites for Semaglutide

The thigh and hip area are the primary approved locations for semaglutide subcutaneous injections. The front and outer thigh—starting about 3 to 4 inches above the knee and stopping several inches below the hip bone—offers good subcutaneous depth and accessibility. The outer hip area, just below the hip bone, is equally effective and often preferred by patients with lower body adiposity or those seeking an alternative rotation point.

Subcutaneous tissue in these leg regions has consistent depth and blood flow, allowing steady medication absorption over the seven-day dosing interval. The abdomen is also approved, but many patients choose legs for privacy, ease of administration, and reduced daily reminders since injections occur once weekly. Buttocks are less commonly used for semaglutide but remain a viable option when thigh and hip sites are unavailable or overused.

How to Identify and Prepare Your Injection Sites

Begin by pinching the skin and subcutaneous fat on your outer thigh or hip to confirm adequate tissue depth—you should feel at least one-half inch of pinchable tissue. Mark out a mental grid of injection points, spacing each site about one inch apart horizontally and vertically to create distinct zones. This systematic approach prevents repeated injections into the same small area, which can lead to lipodystrophy (fat loss or thickening), bruising, and reduced drug absorption.

Clean each injection site with an alcohol swab and allow it to dry for at least 30 seconds before administering your dose. Room-temperature medication injects more smoothly than cold medication, so remove your semaglutide pen or syringe from the refrigerator 15 to 20 minutes before injection. Avoid areas with visible scars, moles, bruises, or hardened tissue, as these sites may have altered blood flow or sensation.

Semaglutide Leg Injection Rotation Strategy

Rotating injection sites is essential for preventing tissue damage and maintaining consistent medication absorption across treatment months. A common strategy involves selecting one leg for weeks one and two, switching to the other leg for weeks three and four, then rotating hip sites in a similar pattern. Within each chosen leg, move your injection site one inch in a different direction each week, creating a spiral or grid pattern that distributes doses across the thigh.

Document your injection sites using a simple chart or photo to track which areas you have already used. Many patients keep a calendar note or use a marking pen to circle the most recent injection spot, making it easy to select the next available site. This disciplined rotation minimizes the risk of nodules, lipoatrophy (indentation), and lipohypertrophy (thickened tissue), all of which can reduce semaglutide's effectiveness over time.

Minimizing Discomfort and Managing Injection Reactions

Fine-gauge needles (31 gauge or thinner) are standard for semaglutide injections and cause minimal pain when inserted at a 45- to 90-degree angle into the pinched subcutaneous fold. Inject slowly and steadily, counting to three as you administer the full dose, to reduce pressure sensation and allow the medication to disperse evenly. After removing the needle, do not rub the site; instead, apply gentle pressure with a clean gauze pad for a few seconds if needed.

Minor bruising, redness, or mild itching at the injection site typically resolves within 24 to 48 hours and does not indicate a problem with your treatment. If you experience persistent redness, warmth, swelling, or signs of infection (pus, increased pain), contact your healthcare provider immediately. Ice applied before injection can numb the area, while a warm compress afterward may reduce stiffness—choose whichever method works best for your comfort and tolerability.

Understanding Semaglutide Absorption and Leg Injection Efficacy

Subcutaneous leg injections deliver semaglutide into the fatty tissue layer beneath your skin, where the medication slowly releases into your bloodstream over seven days. Research shows that absorption rates from the thigh and hip are comparable to abdominal injections, making leg sites equally reliable for maintaining steady GLP-1 receptor activation and appetite suppression. The consistency of leg absorption means your dose does not need adjustment based on injection location, as long as you rotate sites properly.

PlexusDx compounded semaglutide maintains the same bioavailability and pharmacokinetics as brand-name formulations when administered via proper subcutaneous technique. Patients who report inconsistent weight loss results often improve adherence and outcomes by mastering site rotation and injection timing. Your personalized dose may need to increase over time based on your clinical response—not because of injection technique—but correct site selection and rotation will maximize the medication's effectiveness at every dose level.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Can I inject semaglutide in the same leg every week, or do I have to rotate?

Rotating injection sites is strongly recommended to prevent lipodystrophy, bruising, and reduced absorption. While you can use the same leg, move your injection point at least one inch away each week within that leg, or alternate between legs every two weeks. This practice maintains consistent medication delivery and protects your tissue integrity over months of treatment.

What is the ideal needle angle and depth for a leg injection?

Insert the needle at a 45- to 90-degree angle directly into the pinched subcutaneous fat fold on your thigh or hip. The needle should penetrate only into the fatty layer beneath the skin, not into muscle or deeper tissue. A standard 31-gauge needle travels about one-quarter to one-half inch, which is appropriate for most adults with normal body composition.

How much does compounded semaglutide cost at PlexusDx?

PlexusDx compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan, with no membership fee or insurance required. The price remains flat regardless of your dose level—your dose may need to go up, but your price won't. All medications are dispensed from licensed 503A compounding pharmacies and are HSA/FSA eligible.

What should I do if I develop a bruise, lump, or hardness at an injection site?

Minor bruising usually resolves within 24 to 48 hours and is not dangerous. Lumps or hardened areas may indicate lipohypertrophy (tissue thickening) and suggest you need stricter site rotation. If lumps persist, grow larger, or you notice signs of infection, consult your provider. Avoid injecting into these areas until they fully resolve.

Can PlexusDx genetic testing help optimize my semaglutide therapy?

Yes. PlexusDx offers the Precision Peptide Genetic Test ($298) which analyzes your GIPR gene variants, along with 47 other peptide-pathway genes. This test identifies whether you carry genetic predispositions that may affect your response to semaglutide, helping your provider personalize your dose and select the best compound for your unique biology.

Related Reading

• Ro Wegovy
• Mochi Wegovy
• Noom Wegovy
• Hims Wegovy

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.